Results 141 to 150 of about 45,441 (213)

Mantle cell lymphoma presenting primarily as cutaneous lesions: A case report. [PDF]

World J Clin Cases
Zhou PY, Chen W, Wang L.
europepmc   +1 more source

Prognostic impact of cancer-directed surgery in primary pulmonary lymphoma: a population-based, propensity score-matched analysis. [PDF]

Transl Cancer Res
Zhang Y, Chen W, Tian Y.
europepmc   +1 more source

Patterns of Bruton's Tyrosine Kinase Inhibitor (BTKi) Usage in B-cell Lymphomas in India: A Questionnaire-Based Study. [PDF]

Cureus
Naseem A, Pednekar A, Patil S, Barkate H.   +3 more
europepmc   +1 more source

Brute force: the effects of ibrutinib on brexu-cel. [PDF]

Blood Adv
Peterson CE, Betts BC.
europepmc   +1 more source

Small bowel lymphoma presenting with frequent perforation: a single center experience focusing on the monomorphic epitheliotropic intestinal T-cell lymphoma. [PDF]

BMC Gastroenterol
Yeh WC, Han ML, Tu CH, Chen CC, Cheng TY.   +4 more
europepmc   +1 more source

A Case of Reactive Lymphoid Hyperplasia That Is Difficult to Differentiate From Renal Cancer With Lymph Node Metastasis. [PDF]

IJU Case Rep
Nakagawa S, Nakai Y, Hayashi Y, Kurahashi Y, Okamoto S, Nakamura Y, Kawamura N, Nagahara A, Nakayama M, Nishimura K.   +9 more
europepmc   +1 more source

Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies. [PDF]

Blood Cancer J
Umyarova E, Sharp J, Pei C, Pellegrino W, Zhao Q, Denlinger N, Voorhees T, De Lima M, Epperla N.   +8 more
europepmc   +1 more source

<i>Cladosporium cladosporioides</i> Fungemia in a Patient with Non-Hodgkin Lymphoma: An Extremely Rare Case and Review of the Literature. [PDF]

Reports (MDPI)
Niyazi D, Daskalova N, Micheva I, Stoeva T.   +3 more
europepmc   +1 more source

Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults. [PDF]

Blood Adv
Xie Y, Zhou KS, Li LF, Liang AB, Mei H, Zou DH, Li WY, Jin J, Jin ZM, Jing HM, Yang HY, Chen T, Huang HQ, He PC, Cao JN, Xia Z, Gu YE, Zang YB, Zhou ZS, Tian ZZ, Zhu J, Song YQ.   +21 more
europepmc   +1 more source

Secondary primary malignancies in indolent non-Hodgkin lymphoma patients receiving frontline bendamustine-rituximab. [PDF]

Cancer
Davies GA, Prica A, Ante Z, Liu N, Pond GR, Balitsky AK, Suleman A, Mozessohn L.   +7 more
europepmc   +1 more source